
Late breaking news presentation slides
EADV 2024
Pipeline
Formulation | Therapeutic indication | Market size b USD | Phase 2 positive | Clinical PoC | Patient cases | Animal PoC | Biological plausibility |
---|---|---|---|---|---|---|---|
Topical | Alopecia Areata | 3 | ![]() |
![]() |
|||
Topical | Chemotherapy alopecia | No treatment | ![]() |
![]() |
|||
Topical | Plaque psoriasis | 25 | ![]() |
![]() |
|||
Topical | Atopic dermatitis | 15 | ![]() |
![]() |
|||
Topical | Vitiligo | One treatment |
![]() |
![]() |
|||
Oral | Cancer related fatigue | No treatment | ![]() |
![]() |
|||
Oral | Inflammatory indications | ![]() |
|||||
Total | > 50 |
Collaborations & Partners










